Logo image of LEN.B

LENNAR CORP - B SHS (LEN.B) Stock Fundamental Analysis

NYSE:LEN.B - New York Stock Exchange, Inc. - US5260573028 - Common Stock - Currency: USD

100.81  +0.14 (+0.14%)

After market: 100.81 0 (0%)

Fundamental Rating

7

LEN.B gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 64 industry peers in the Household Durables industry. Both the health and profitability get an excellent rating, making LEN.B a very profitable company, without any liquidiy or solvency issues. LEN.B has a correct valuation and a medium growth rate. These ratings could make LEN.B a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year LEN.B was profitable.
In the past year LEN.B had a positive cash flow from operations.
Each year in the past 5 years LEN.B has been profitable.
In the past 5 years LEN.B always reported a positive cash flow from operatings.
LEN.B Yearly Net Income VS EBIT VS OCF VS FCFLEN.B Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

LEN.B has a better Return On Assets (10.56%) than 78.13% of its industry peers.
LEN.B's Return On Equity of 16.26% is fine compared to the rest of the industry. LEN.B outperforms 70.31% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.43%, LEN.B is in the better half of the industry, outperforming 71.88% of the companies in the same industry.
LEN.B had an Average Return On Invested Capital over the past 3 years of 12.52%. This is in line with the industry average of 11.93%.
Industry RankSector Rank
ROA 10.56%
ROE 16.26%
ROIC 11.43%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.52%
ROIC(5y)11.96%
LEN.B Yearly ROA, ROE, ROICLEN.B Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

LEN.B's Profit Margin of 10.34% is amongst the best of the industry. LEN.B outperforms 81.25% of its industry peers.
In the last couple of years the Profit Margin of LEN.B has grown nicely.
LEN.B has a better Operating Margin (13.74%) than 81.25% of its industry peers.
LEN.B's Operating Margin has improved in the last couple of years.
LEN.B's Gross Margin of 15.21% is on the low side compared to the rest of the industry. LEN.B is outperformed by 92.19% of its industry peers.
LEN.B's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.74%
PM (TTM) 10.34%
GM 15.21%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
LEN.B Yearly Profit, Operating, Gross MarginsLEN.B Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LEN.B is creating some value.
Compared to 1 year ago, LEN.B has less shares outstanding
LEN.B has less shares outstanding than it did 5 years ago.
The debt/assets ratio for LEN.B has been reduced compared to a year ago.
LEN.B Yearly Shares OutstandingLEN.B Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LEN.B Yearly Total Debt VS Total AssetsLEN.B Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 4.19 indicates that LEN.B is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.19, LEN.B is in the better half of the industry, outperforming 67.19% of the companies in the same industry.
LEN.B has a debt to FCF ratio of 2.27. This is a good value and a sign of high solvency as LEN.B would need 2.27 years to pay back of all of its debts.
LEN.B has a better Debt to FCF ratio (2.27) than 70.31% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that LEN.B is not too dependend on debt financing.
LEN.B has a better Debt to Equity ratio (0.16) than 71.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.27
Altman-Z 4.19
ROIC/WACC1.33
WACC8.58%
LEN.B Yearly LT Debt VS Equity VS FCFLEN.B Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

LEN.B has a Current Ratio of 8.37. This indicates that LEN.B is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.37, LEN.B belongs to the best of the industry, outperforming 89.06% of the companies in the same industry.
LEN.B has a Quick Ratio of 1.84. This is a normal value and indicates that LEN.B is financially healthy and should not expect problems in meeting its short term obligations.
LEN.B has a Quick ratio of 1.84. This is amongst the best in the industry. LEN.B outperforms 82.81% of its industry peers.
Industry RankSector Rank
Current Ratio 8.37
Quick Ratio 1.84
LEN.B Yearly Current Assets VS Current LiabilitesLEN.B Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

LEN.B shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.78%.
LEN.B shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.01% yearly.
Looking at the last year, LEN.B shows a small growth in Revenue. The Revenue has grown by 2.01% in the last year.
Measured over the past years, LEN.B shows a quite strong growth in Revenue. The Revenue has been growing by 9.75% on average per year.
EPS 1Y (TTM)-3.78%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-23.74%
Revenue 1Y (TTM)2.01%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%4.36%

3.2 Future

Based on estimates for the next years, LEN.B will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.67% on average per year.
The Revenue is expected to grow by 5.72% on average over the next years.
EPS Next Y-27.99%
EPS Next 2Y-8.17%
EPS Next 3Y2.27%
EPS Next 5Y10.67%
Revenue Next Year0.9%
Revenue Next 2Y2.61%
Revenue Next 3Y4.43%
Revenue Next 5Y5.72%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LEN.B Yearly Revenue VS EstimatesLEN.B Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
LEN.B Yearly EPS VS EstimatesLEN.B Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

LEN.B is valuated cheaply with a Price/Earnings ratio of 7.34.
Based on the Price/Earnings ratio, LEN.B is valued a bit cheaper than 68.75% of the companies in the same industry.
LEN.B's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.82.
With a Price/Forward Earnings ratio of 8.34, the valuation of LEN.B can be described as very reasonable.
LEN.B's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LEN.B is cheaper than 62.50% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, LEN.B is valued rather cheaply.
Industry RankSector Rank
PE 7.34
Fwd PE 8.34
LEN.B Price Earnings VS Forward Price EarningsLEN.B Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LEN.B is valued a bit cheaper than the industry average as 78.13% of the companies are valued more expensively.
LEN.B's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 16.71
EV/EBITDA 5.49
LEN.B Per share dataLEN.B EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

LEN.B has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y-8.17%
EPS Next 3Y2.27%

6

5. Dividend

5.1 Amount

LEN.B has a Yearly Dividend Yield of 1.82%.
LEN.B's Dividend Yield is a higher than the industry average which is at 3.47.
LEN.B's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.82%

5.2 History

On average, the dividend of LEN.B grows each year by 65.54%, which is quite nice.
LEN.B has been paying a dividend for at least 10 years, so it has a reliable track record.
LEN.B has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)65.54%
Div Incr Years1
Div Non Decr Years15
LEN.B Yearly Dividends per shareLEN.B Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

14.64% of the earnings are spent on dividend by LEN.B. This is a low number and sustainable payout ratio.
LEN.B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP14.64%
EPS Next 2Y-8.17%
EPS Next 3Y2.27%
LEN.B Yearly Income VS Free CF VS DividendLEN.B Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B
LEN.B Dividend Payout.LEN.B Dividend Payout, showing the Payout Ratio.LEN.B Dividend Payout.PayoutRetained Earnings

LENNAR CORP - B SHS

NYSE:LEN.B (5/23/2025, 8:31:25 PM)

After market: 100.81 0 (0%)

100.81

+0.14 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-20 2025-03-20/amc
Earnings (Next)06-16 2025-06-16/amc
Inst Owners96.41%
Inst Owner Change-0.9%
Ins Owners1.77%
Ins Owner ChangeN/A
Market Cap26.59B
Analysts70
Price Target136.82 (35.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.82%
Yearly Dividend2
Dividend Growth(5Y)65.54%
DP14.64%
Div Incr Years1
Div Non Decr Years15
Ex-Date04-23 2025-04-23 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.28%
Min EPS beat(2)-3.31%
Max EPS beat(2)11.86%
EPS beat(4)3
Avg EPS beat(4)7.52%
Min EPS beat(4)-3.31%
Max EPS beat(4)16.11%
EPS beat(8)7
Avg EPS beat(8)10.85%
EPS beat(12)10
Avg EPS beat(12)10.69%
EPS beat(16)12
Avg EPS beat(16)7.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)1.88%
Revenue beat(8)6
Avg Revenue beat(8)2.52%
Revenue beat(12)8
Avg Revenue beat(12)2.42%
Revenue beat(16)12
Avg Revenue beat(16)2.39%
PT rev (1m)-0.99%
PT rev (3m)-12.75%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-27.55%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)-17.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.35%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-3.92%
Valuation
Industry RankSector Rank
PE 7.34
Fwd PE 8.34
P/S 0.74
P/FCF 16.71
P/OCF 15.23
P/B 1.17
P/tB 1.39
EV/EBITDA 5.49
EPS(TTM)13.73
EY13.62%
EPS(NY)12.09
Fwd EY12%
FCF(TTM)6.03
FCFY5.99%
OCF(TTM)6.62
OCFY6.57%
SpS135.56
BVpS86.16
TBVpS72.39
PEG (NY)N/A
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 10.56%
ROE 16.26%
ROCE 14.98%
ROIC 11.43%
ROICexc 12.38%
ROICexgc 18.99%
OM 13.74%
PM (TTM) 10.34%
GM 15.21%
FCFM 4.45%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.52%
ROIC(5y)11.96%
ROICexc(3y)14.71%
ROICexc(5y)13.75%
ROICexgc(3y)18.6%
ROICexgc(5y)16.93%
ROCE(3y)16.4%
ROCE(5y)15.67%
ROICexcg growth 3Y-0.73%
ROICexcg growth 5Y10.92%
ROICexc growth 3Y-5.57%
ROICexc growth 5Y8.18%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.27
Debt/EBITDA 0.72
Cap/Depr 129.15%
Cap/Sales 0.43%
Interest Coverage 250
Cash Conversion 34.71%
Profit Quality 43.07%
Current Ratio 8.37
Quick Ratio 1.84
Altman-Z 4.19
F-Score6
WACC8.58%
ROIC/WACC1.33
Cap/Depr(3y)101.58%
Cap/Depr(5y)91.5%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.3%
Profit Quality(3y)86.08%
Profit Quality(5y)96.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.78%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-23.74%
EPS Next Y-27.99%
EPS Next 2Y-8.17%
EPS Next 3Y2.27%
EPS Next 5Y10.67%
Revenue 1Y (TTM)2.01%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%4.36%
Revenue Next Year0.9%
Revenue Next 2Y2.61%
Revenue Next 3Y4.43%
Revenue Next 5Y5.72%
EBIT growth 1Y-14.59%
EBIT growth 3Y-1.69%
EBIT growth 5Y12.56%
EBIT Next Year-24.81%
EBIT Next 3Y0.46%
EBIT Next 5Y5.82%
FCF growth 1Y-62.63%
FCF growth 3Y-3.29%
FCF growth 5Y9.84%
OCF growth 1Y-59.54%
OCF growth 3Y-1.73%
OCF growth 5Y10.15%